BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li Y, Sharma A, Maciaczyk J, Schmidt-Wolf IGH. Recent Development in NKT-Based Immunotherapy of Glioblastoma: From Bench to Bedside. Int J Mol Sci 2022;23:1311. [PMID: 35163235 DOI: 10.3390/ijms23031311] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Bayatipoor H, Mehdizadeh S, Jafarpour R, Shojaei Z, Pashangzadeh S, Motallebnezhad M. Role of NKT cells in cancer immunotherapy-from bench to bed. Med Oncol 2022;40:29. [PMID: 36460881 DOI: 10.1007/s12032-022-01888-5] [Reference Citation Analysis]
2 Jia J, Han Z, Wang X, Zheng X, Wang S, Cui Y. H2B gene family: A prognostic biomarker and correlates with immune infiltration in glioma. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.966817] [Reference Citation Analysis]
3 Yusuf S, Aretz P, Nickel A, Westhoff P, Sharma A, Qin N, Remke M, Steiger H, Hänggi D, Liu H, Liu H, Neumann S, Reifenberger G, Maciaczyk J. WNT/β-Catenin-Mediated Resistance to Glucose Deprivation in Glioblastoma Stem-like Cells. Cancers 2022;14:3165. [DOI: 10.3390/cancers14133165] [Reference Citation Analysis]
4 Aretz P, Maciaczyk D, Yusuf S, Sorg RV, Hänggi D, Liu H, Liu H, Dakal TC, Sharma A, Bethanabatla R, Neumann S, Maciaczyk J. Crosstalk between β-Catenin and CCL2 Drives Migration of Monocytes towards Glioblastoma Cells. Int J Mol Sci 2022;23:4562. [PMID: 35562953 DOI: 10.3390/ijms23094562] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]